Amyotrophic lateral sclerosis treatment
2007
The provision of new amyotrophic lateral sclerosis therapeutics. Amyotrophic lateral sclerosis therapeutic agents characterized by containing a compound which does not have a xanthine dehydrogenase inhibitory activity and a substrate for purine salvage pathway.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI